Clinical Trials Browser

Uterine Cervical Neoplasms, Vaginal Neoplasms

Locally Advanced Cervical Adenocarcinoma

Endometrial Neoplasms

Endometrial Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Cervical Esophagus Adenocarcinoma

Endometrial Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Uterine Cervical Neoplasms

Gynecologic Cancer

Endometrial Serous Adenocarcinoma

Stage IA Uterine Sarcoma

Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation

Carcinoma, Uterine Cervical Neoplasms

Vulvar Neoplasms

Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Recurrence

Uterine Cervical Neoplasms, Prostatic Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms, Endometrial Neoplasms

Uterine Cervical Neoplasms, Radiation Injuries

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

Carcinoma, Renal Cell, Chondrosarcoma, Kidney Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Osteosarcoma

Uterine Cervical Neoplasms

Clinical Trials

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy

Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

DeCRESCEndo

Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery

Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer

ATGCRT

Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma

Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

RCMI PELVIS

Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer

High Dose Intensity Modulated Radiation Therapy in the Cervical Cancer With Metastatic Lymphadenopathies.

DEPICT

Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery

the Re-irradiation of Recurrent Cervical Cancer by IMRT

Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain

Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients